| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.54 | 0.07 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.23 | 5e-05 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.2 | 0.03 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.19 | 0.5 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.18 | 0.0003 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.18 | 0.0007 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 9e-06 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.006 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.16 | 5e-05 |